<DOC>
	<DOCNO>NCT01372462</DOCNO>
	<brief_summary>Pilot study 15 stable male subject severe-to-very severe Chronic Obstructive Pulmonary Disease ( COPD ) evaluate effect short term use Breathe Technologies noninvasive open ventilation ( NIOV ) system respiratory mechanic constant work rate exercise subject severe COPD .</brief_summary>
	<brief_title>Effects Breathe Technologies Ventilation System Subjects With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Study randomize double-blinded crossover design subject complete series exercise constant work rate use 1 ) Test noninvasive ventilation ( NIOV ) system power compressed air , 2 ) Test NIOV system power 100 % oxygen , 3 ) nasal cannula oxygen , 4 ) nothing ( Control ) . Subjects assess constant work rate exercise reflect exercise duration , isotime oxygenation ( SpO2 ) , isotime dyspnea score ( Borg ) . Exercise session take place 4 visit visit last approximately 5 hour .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Adult male , â‰¥ 40 year age Diagnosis severe COPD ( GOLD stage III IV ) define FEV1 &lt; 50 % predict FEV1/FVC ratio &lt; 70 % predict Ventilatory limitation exercise , document VE/MVV &gt; 0.85 SpO2 80 % 88 % incremental exercise test room air Willingness ability ( train ) exercise cycle ergometer Willingness ability perform study relate procedure task Ability properly fit Breathe nasal mask Ability tolerate appropriately titrate Breathe ventilator ( See Appendix E ) Ability properly fit exercise mask Fluency write spoken English Provision write informed consent History acute exacerbation COPD within 30 day screen History serious epistaxis within 14 day screen Requirement &gt; 5 LPM nasal O2 maintain SpO2 &gt; 90 % rest History pneumothorax secondary lung bulla History intolerance supplemental oxygen Musculoskeletal nonpulmonary impairment limit exercise tolerance Inability achieve optimal CWR level ( 47 minute ) Study Visit 1R Current participation another interventional study participation within 14 day screen Presence condition abnormality opinion Principal Investigator may compromise subject 's safety quality study data</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Ventilator</keyword>
	<keyword>Constant work rate</keyword>
</DOC>